Efficacy and tolerability of open-label topiramate in the treatment of sleep-related eating disorder: A retrospective case series

Journal of Clinical Psychiatry

Volumn 67, Issue 11, 2006, Pages 1729-1734

  Winkelman, John W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; TOPIRAMATE;

ADULT; AMNESIA; ANXIETY; APNEA; BICARBONATE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COGNITION; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEMOGRAPHY; DEPRESSION; DIAGNOSTIC TEST; DREAMING; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TOLERANCE; DRUG WITHDRAWAL; EATING DISORDER; EYE MOVEMENT DISORDER; FEMALE; FOLLOW UP; HEADACHE; HUMAN; IRRITABILITY; MALE; MEDICAL RECORD; MEMORY; NAUSEA; PARESTHESIA; POLYSOMNOGRAPHY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SLEEP RELATED EATING DISORDER; TACHYPHYLAXIS; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VISUAL ILLUSION; WEIGHT REDUCTION;

EID: 33745694043     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n1109     Document Type: Review

References (22)

1. Schenck CH, Hurwitz TD, Bundlie SR, et al. Sleep-related eating disorders: polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disorders. Sleep 1991;14:419-431
2. Winkelman JW. Clinical and polysomnographic features of sleep-related eating disorder. J Clin Psychiatry 1998;59:14-19
3. American Academy of Sleep Medicine. The International Classification of Sleep Disorders (Revised-2): Diagnostic and Coding Manual. Rochester, Minn: American Academy of Sleep Medicine; 2005
4. Winkelman JW, Herzog DB, Fava M. The prevalence of sleep-related eating disorder in psychiatric and non-psychiatric populations. Psychol Med 1999;29:1461-1466
5. Rand CS, MacGregor AM, Stunkard AJ. The night eating syndrome in the general population and among postoperative obesity surgery patients. Int J Eat Disord 1997;22:65-69
6. Schenck CH, Hurwitz TD, O'Connor KA, et al. Additional categories of sleep-related eating disorders and the current status of treatment. Sleep 1993;16:457-466
7. Provini F, Albani F, Vetrugno R, et al. A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder. Eur J Neurol 2005;12:432-436
8. O'Reardon JP, Peshek A, Allison KC. Night eating syndrome: diagnosis, epidemiology and management. CNS Drugs 2005;19:997-1008
9. Langtry HD, Gillis JC, Davis R. Topiramate: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs 1997;54:752-773
10. Reife R, Pledger G, Wu SC. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 2000;41(suppl 1): S66-S71
11. McIntyre RS, Mancini DA, McCann S, et al. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord 2002;4:207-213
12. Ondo WG, Jankovic J, Connor GS, et al. Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology 2006;66:672-677
13. Shapira NA, Goldsmith TD, McElroy SL. Treatment of binge-eating disorder with topiramate: a clinical case series. J Clin Psychiatry 2000; 61:368-372
14. McElroy SL, Shapira NA, Arnold LM, et al. Topiramate in the long-term treatment of binge-eating disorder associated with obesity. J Clin Psychiatry 2004;65:1463-1469
15. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
16. Winkelman JW. Treatment of nocturnal eating syndrome and sleep-related eating disorder with topiramate. Sleep Med 2003;4:243-246
17. Spaggiari MC, Granella F, Parrino L, et al. Nocturnal eating syndrome in adults. Sleep 1994;17:339-344
18. Morgenthaler TI, Silber MH. Amnestic sleep-related eating disorder associated with zolpidem. Sleep Med 2002;3:323-327
19. Schenck CH, Connoy DA, Castellanos M, et al. Zolpidem-induced amnestic sleep-related eating disorder (SRED) in 19 patients. Sleep 2005;28(abstract supplement):A259
20. Wilkes JJ, Nelson E, Osborne M, et al. Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats. Am J Physiol Endocrinol Metab 2005;288:E617-E624
21. Liang Y, Chen X, Osborne M, et al. Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db/db mice. Diabetes Obes Metab 2005;7:360-369
22. Silberstein SD, Ben-Menachem E, Shank RP, et al. Topiramate monotherapy in epilepsy and migraine prevention. Clin Ther 2005;27:154-165